PR Newswire

Recently

Kyowa Kirin and Kura Oncology Initiate Japanese Phase 2 Registration-Directed Trial of Ziftomenib in R/R NPM1-m AML

– Regulatory Filing in Japan Planned Following Clinical [...]

Changan Group Unveils Updated “Vast Ocean Plan 2.0” and highlight Next-Generation BlueCore Hybrid at Auto China 2026

Building on Changan Group’s long-term “1+4+4+5” strategy, the [...]

Kerry Properties Presents Asia’s Signature Ice Hockey Event

2026 Mega Ice Hockey 5’s Set to Begin [...]

HanchorBio Selects Bloomberg to Strengthen its Strategic Intelligence Across Drug Development and Global Biopharma

Expanding HanchorBio’s data-enabled approach from molecule design to [...]

Dingdong Files Its Annual Report on Form 20-F

SHANGHAI, April 24, 2026 /PRNewswire/ — Dingdong (Cayman) [...]